The Vincent Center for Reproductive Biology provides an environment that exposes clinicians to an integrated clinical and basic research program.
There are numerous projects ongoing within the Vincent Center for Reproductive Biology (VCRB) with emphasis on ovarian and uterine cancer, fetal/maternal interactions, menopause, infertility, and ovarian cell signaling.
Our goal is to provide each clinical research fellow with the opportunity to design, implement and critically review basic research projects on clinically important topics.
Opportunities are available for clinicians who are in an MGH fellowship. Contact any one of our faculty to find out more.
Mass General Brigham researchers found that getting vaccinated on the early side of the recommended window was best for transferring maternal antibodies to the fetus.
Immune activation in a pregnant woman can occur in response to metabolic diseases like obesity, infections in pregnancy, exposure to pollution and environmental toxins, or even stress and can have negative effects on fetal brain immune cells (microglia).
The world of medicine has made remarkable strides in diagnosing and treating various health conditions, but when it comes to many women’s health issues, progress is lacking.
Maternal SARS‐CoV‐2 positivity during pregnancy was associated with nearly two-fold higher odds of a neurodevelopmental diagnosis at 12 months of age among male children.
In the largest study of its kind to date, researchers have found the new mRNA COVID-19 vaccines to be highly effective in producing antibodies against the SARS-CoV-2 virus in pregnant and lactating women.
En el mayor estudio de este tipo realizado hasta la fecha, los investigadores han descubierto que las nuevas vacunas de ARNm contra el COVID-19 son muy eficaces para producir anticuerpos contra el virus del SARS-CoV-2 en mujeres embarazadas y lactantes.